nicotine has been researched along with threonine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arneric, SP; Briggs, CA; Gopalakrishnan, M; McKenna, DG; Monteggia, LM; Roch, JM; Sullivan, JP; Touma, E | 1 |
| Broide, RS; Dani, JA; De Biasi, M; Ji, D; Patrick, JW; Paylor, R; Salas, R | 1 |
| Greengard, P; Hamada, M; Higashi, H; Nairn, AC; Nishi, A | 1 |
| Cashin, AL; Dougherty, DA; Lester, HA; Petersson, EJ | 1 |
| Baldwin, IT; Giri, A; Kang, JH; Wang, L | 1 |
5 other study(ies) available for nicotine and threonine
| Article | Year |
|---|---|
Gain of function mutation of the alpha7 nicotinic receptor: distinct pharmacology of the human alpha7V274T variant.
Topics: Acetylcholine; Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Amino Acid Substitution; Animals; Atropine; Choline; Dihydro-beta-Erythroidine; Dimethylphenylpiperazinium Iodide; Dose-Response Relationship, Drug; Genetic Variation; Humans; Lobeline; Mecamylamine; Membrane Potentials; Muscarinic Antagonists; Mutation; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oocytes; Pyridines; Pyrrolidines; Receptors, Nicotinic; Threonine; Tubocurarine; Valine; Xenopus | 1999 |
Increased sensitivity to nicotine-induced seizures in mice expressing the L250T alpha 7 nicotinic acetylcholine receptor mutation.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Amino Acid Substitution; Animals; Dihydro-beta-Erythroidine; Disease Models, Animal; Electrophysiology; Female; Ganglionic Stimulants; Heterozygote; Hippocampus; Lysine; Male; Mice; Mice, Inbred C57BL; Neuroanatomy; Nicotine; Phenotype; Receptors, Nicotinic; Seizures; Threonine | 2002 |
Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzazepines; Blotting, Western; Bungarotoxins; Cyclosporine; Dihydro-beta-Erythroidine; Dizocilpine Maleate; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; In Vitro Techniques; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Models, Neurological; Neostriatum; Nerve Tissue Proteins; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Phosphoproteins; Phosphorylation; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Tetrodotoxin; Threonine | 2004 |
Using physical chemistry to differentiate nicotinic from cholinergic agonists at the nicotinic acetylcholine receptor.
Topics: Acetylcholine; Animals; Bridged Bicyclo Compounds, Heterocyclic; Chemical Phenomena; Chemistry, Physical; Cholinergic Agonists; Crystallography, X-Ray; Hydrogen Bonding; Kinetics; Models, Molecular; Nicotine; Nicotinic Agonists; Pyridines; Receptors, Nicotinic; Static Electricity; Surface Properties; Threonine; Tryptophan; Xenopus laevis | 2005 |
Silencing threonine deaminase and JAR4 in Nicotiana attenuata impairs jasmonic acid-isoleucine-mediated defenses against Manduca sexta.
Topics: Animals; Butyrates; Cyclopentanes; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Plant; Gene Silencing; Immunity, Innate; Isoleucine; Manduca; Molecular Sequence Data; Nicotiana; Nicotine; Oxylipins; Plant Diseases; Plant Leaves; Plant Viruses; RNA, Messenger; Signal Transduction; Suppression, Genetic; Threonine; Threonine Dehydratase; Trypsin Inhibitors | 2006 |